Boston, MA · Founded 2017 · Privately Held (backing)
Developer of drug therapies designed to improve the lives of people as they age. Life Biosciences is based in Boston, MA and was founded in 2017. Its last reported valuation was $500 million in Jan 2019. It has raised $255 million across 3 recorded rounds; the latest was a $31 million early-stage round in Nov 2025.
Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$255.2M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record
Life Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Life Biosciences with a free account
·The complete investor list: 16 names
·Watch Life Biosciences: the Monday email on marks, rounds and moves
Where does Life Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Life Biosciences's 3 recorded funding rounds.
